PLK1 and esophageal squamous cell carcinoma: In ESCC, downregulation of polo like kinase 1 (PLK1) could block the pentose phosphate pathway to impair the production of NADPH, thereby enhancing ferroptosis and promoting the sensitivity of ESCC cells to chemotherapy (Zhao et al., 2023).